Uni-Bio Science Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	179.89	65.01	129.24	98.22	83.61
Short-Term Investments	-	118.89	12.36	10.4	6.72
Cash & Short-Term Investments	179.89	183.9	141.59	108.62	90.33
Cash Growth	-2.18%	29.88%	30.35%	20.26%	17.82%
Accounts Receivable	108.74	70.24	53.22	57.87	71.63
Other Receivables	-	0.19	0.59	-	-
Receivables	117.44	101.1	60.11	57.87	71.63
Inventory	37	33.78	36.39	33.85	39.71
Total Current Assets	334.34	318.78	238.1	200.34	201.67
Property, Plant & Equipment	178.08	138.34	104.08	59.87	57.45
Long-Term Investments	8.87	-	-	-	-
Other Intangible Assets	38.2	2.24	2.67	3.09	3.81
Long-Term Deferred Tax Assets	2.58	4.12	3.85	0.43	-
Long-Term Deferred Charges	-	34.22	36.59	21.03	4.37
Other Long-Term Assets	5.63	19.44	15.47	7.71	0.3
Total Assets	579.8	517.55	409.99	292.47	267.59
Accounts Payable	40.93	15.23	9.31	5.27	5.26
Accrued Expenses	-	22.8	38.8	27.96	43.21
Short-Term Debt	5.22	5.26	8.86	0.13	-
Current Portion of Long-Term Debt	32.33	43.31	11.04	11.19	-
Current Portion of Leases	5.92	6.18	4.23	4.01	4.61
Current Income Taxes Payable	0.87	2.41	2.18	3.11	1.72
Current Unearned Revenue	18.29	17.67	25.16	21.81	20.21
Other Current Liabilities	-	10.64	15.22	16.78	17.29
Total Current Liabilities	103.55	123.5	114.79	90.26	92.3
Long-Term Debt	55.51	56.01	30.61	-	-
Long-Term Leases	3.99	9.7	6.99	7.47	0.99
Long-Term Unearned Revenue	1.97	0.26	-	-	-
Long-Term Deferred Tax Liabilities	1.53	2.45	0.43	-	-
Total Liabilities	166.56	191.91	152.82	97.73	93.29
Common Stock	59.71	59.71	63.65	63.65	63.5
Additional Paid-In Capital	-	725.69	751.76	751.76	750.77
Retained Earnings	-	-544.52	-628.48	-699.36	-737.87
Treasury Stock	-	-	-5.17	-	-
Comprehensive Income & Other	353.54	84.76	75.42	78.7	97.91
Shareholders' Equity	413.25	325.65	257.17	194.75	174.31
Total Liabilities & Equity	579.8	517.55	409.99	292.47	267.59
Total Debt	102.97	120.45	61.73	22.8	5.6
Net Cash (Debt)	76.92	63.45	79.87	85.82	84.73
Net Cash Growth	21.23%	-20.55%	-6.94%	1.29%	15.23%
Net Cash Per Share	0.01	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	5,994	5,971	6,279	6,365	6,350
Total Common Shares Outstanding	5,994	5,971	6,279	6,365	6,350
Working Capital	230.79	195.28	123.31	110.09	109.36
Book Value Per Share	0.07	0.05	0.04	0.03	0.03
Tangible Book Value	375.05	323.41	254.51	191.66	170.5
Tangible Book Value Per Share	0.06	0.05	0.04	0.03	0.03
Buildings	-	86.67	87.95	88.88	90.45
Machinery	-	160.98	118.54	117.24	127.38
Construction In Progress	-	41.11	54.56	5.81	2.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.